| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.6 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |